FDA
approval
· 2021-11-03
FDA Approved: GATIFLOXACIN — Original Application (Leading Pharma, LLC)
Summary
FDA approved gatifloxacin ophthalmic solution 0.5% under an original ANDA from Leading Pharma, LLC for use in treating bacterial conjunctivitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for GATIFLOXACIN (GATIFLOXACIN)